Customer Login

About
Pipeline
Products
- Zimeta^™ (dipyrone injection)
Technology
- Veterinary Recombinant Biologics
- Manufacturing Process
Education
- Continuing Education
- KINections
Investors
News
- Press Releases
Contact Us
- Contact Us
- Careers
Menu

Test PI PDF Embed

You are here: Home / Test PI PDF Embed

Mirataz_Full_PI

News

Kindred Biosciences Announces Plan to Strengthen its Strategic PositionJune 8, 2020 - 4:04 pm
Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with VaxartMay 20, 2020 - 8:02 am
Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws ConferenceMay 13, 2020 - 8:38 am

Events

Event: Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws ConferenceMay 13, 2020 - 8:39 am
Event: Kindred Biosciences to Announce First Quarter 2020 Financial ResultsApril 23, 2020 - 8:37 am
Event: Kindred Biosciences to Announce Fourth Quarter and Year-End 2019 Financial ResultsMarch 3, 2020 - 4:05 pm

$4.43

-0.02 (-0.45%)

KIN (Common Stock)
Previous Close	Volume
$4.45	45,959
Intraday High	Intraday Low
$4.49	$4.34
52 Week High	52 Week Low
$11.93	$3.10
Exchange: NASDAQ CM

KindredBio proudly supports
Rabies Free Africa

Contact Us | Careers | Privacy Policy | Website Terms of Use | Forward Looking Statements

© Copyright 2012-2020 | Kindred Biosciences, Inc. | 1555 Bayshore Hwy. Suite 200 Burlingame, CA 94010